Skip to main content
Advertisement
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
      • Doodle Gallery
      • Circulation Cover Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
      • Hospital Santa Maria del Popolo, Naples, Italy
      • Minneapolis City Hospital
      • Pitié-Salpêtrière Hospital
      • Tufts Medical Center
      • Uppsala University Hospital
      • Vassar Brothers Medical Center (Poughkeepsie, NY)
      • Wroclaw Medical University
    • On My Mind
    • Podcast Archive
      • → Circulation on the Run, FIT Edition
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association

Search for author "A. Michael Lincoff"

  • Modify Search
  • Create Alert
  • Save Search

15 Results

Type a term to search within all articles in this journal: e.g., stem cell
Content Type
Select types of content to include in the results.
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
e.g., 07/28/2017
e.g., 07/28/2017
Format Results
  • You have access
    Association of Glycemic Control With Mortality in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
    Praneet K. Sharma, Shikhar Agarwal, Stephen G. Ellis, Sachin S. Goel, Leslie Cho, E. Murat Tuzcu, A. Michael Lincoff, Samir R. Kapadia
    Circulation: Cardiovascular Interventions August 2014, 7 (4) 503-509; DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.113.001107
    View table
    Table 1.
    Baseline Characteristics of Patients Undergoing Percutaneous Coronary Intervention According to Baseline HbA1cShow More
    Baseline Characteristics of Patients Undergoing Percutaneous Coronary Intervention According to Baseline HbA1cShow Less
  • You have access
    Association of Glycemic Control With Mortality in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
    Praneet K. Sharma, Shikhar Agarwal, Stephen G. Ellis, Sachin S. Goel, Leslie Cho, E. Murat Tuzcu, A. Michael Lincoff, Samir R. Kapadia
    Circulation: Cardiovascular Interventions August 2014, 7 (4) 503-509; DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.113.001107
    Figure 1.
    Figure 1.
    Adjusted all-cause mortality. Top, Age- and sex-adjusted all-cause mortality stratified acc...
    Show More
    Adjusted all-cause mortality. Top, Age- and sex-adjusted all-cause mortality stratified according to the hemoglobin A1c (HbA1c) level. Bottom, Respective estimates after multivariable adjustment using stepwise regression in a Cox proportional hazard model. All baseline demographic and clinical characteristics were entered into the model with a retention P value of 0.20. Besides the HbA1c category, the variables included in the final model were age, race, acute coronary syndrome, heart rate on presentation, systolic blood pressure on presentation, history of cerebrovascular accident, chronic obstructive pulmonary disease, renal failure, peripheral vascular occlusive disease, hypertension, family history of coronary artery disease, left main trunk disease, calcification, use of drug-eluting stent, and final thrombolysis in myocardial infarction flow <3. CI indicates confidence interval; and HR, hazard ratio.
    Show Less
  • You have access
    Association of Glycemic Control With Mortality in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
    Praneet K. Sharma, Shikhar Agarwal, Stephen G. Ellis, Sachin S. Goel, Leslie Cho, E. Murat Tuzcu, A. Michael Lincoff, Samir R. Kapadia
    Circulation: Cardiovascular Interventions August 2014, 7 (4) 503-509; DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.113.001107
    Figure 2.
    Figure 2.
    Time to event curves depicting adjusted cumulative hazard of death according to hemoglobin A1c (HbA1c) category. The table below the graph depicts the...Show More
    Time to event curves depicting adjusted cumulative hazard of death according to hemoglobin A1c (HbA1c) category. The table below the graph depicts the number of patients in each category who were at risk of dying at each time interval (in days).Show Less
  • You have access
    Association of Glycemic Control With Mortality in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
    Praneet K. Sharma, Shikhar Agarwal, Stephen G. Ellis, Sachin S. Goel, Leslie Cho, E. Murat Tuzcu, A. Michael Lincoff, Samir R. Kapadia
    Circulation: Cardiovascular Interventions August 2014, 7 (4) 503-509; DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.113.001107
    Figure 3.
    Figure 3.
    The figure demonstrates independent predictors of all-cause mortality derived from the multivariable Cox pro...
    Show More
    The figure demonstrates independent predictors of all-cause mortality derived from the multivariable Cox proportional hazard modeling, using backward stepwise elimination at a retention P value of 0.20. BP indicates blood pressure; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; DES, drug-eluting stent; HbA1c, hemoglobin A1c; HR, hazard ratio; LMT, left main trunk; PVD, peripheral vascular disease; and TIMI, thrombolysis in myocardial infarction.
    Show Less
  • You have access
    Association of Glycemic Control With Mortality in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
    Praneet K. Sharma, Shikhar Agarwal, Stephen G. Ellis, Sachin S. Goel, Leslie Cho, E. Murat Tuzcu, A. Michael Lincoff, Samir R. Kapadia
    Circulation: Cardiovascular Interventions August 2014, 7 (4) 503-509; DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.113.001107
    View table
    Table 2.
    Baseline Characteristics of Insulin Users and Noninsulin Users Undergoing Percutaneous Coronary InterventionShow More
    Baseline Characteristics of Insulin Users and Noninsulin Users Undergoing Percutaneous Coronary InterventionShow Less
  • You have access
    Association of Glycemic Control With Mortality in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
    Praneet K. Sharma, Shikhar Agarwal, Stephen G. Ellis, Sachin S. Goel, Leslie Cho, E. Murat Tuzcu, A. Michael Lincoff, Samir R. Kapadia
    Circulation: Cardiovascular Interventions August 2014, 7 (4) 503-509; DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.113.001107
    Figure 4.
    Figure 4.
    Adjusted hazard of death among (A) noninsulin and (B) insulin users strati...
    Show More
    Adjusted hazard of death among (A) noninsulin and (B) insulin users stratified by hemoglobin A1c (HbA1c) category. CI indicates confidence interval; and HR, hazard ratio.
    Show Less
  • You have access
    Association of Glycemic Control With Mortality in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
    Praneet K. Sharma, Shikhar Agarwal, Stephen G. Ellis, Sachin S. Goel, Leslie Cho, E. Murat Tuzcu, A. Michael Lincoff, Samir R. Kapadia
    Circulation: Cardiovascular Interventions August 2014, 7 (4) 503-509; DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.113.001107
    Figure 5.
    Figure 5.
    Adjusted hazard of death among noninsulin users and insulin users comparing patients with hemoglobin A1c (HbA1c) ≤7.0 (lowest category) as compared wi...Show More
    Adjusted hazard of death among noninsulin users and insulin users comparing patients with hemoglobin A1c (HbA1c) ≤7.0 (lowest category) as compared with those with HbA1c >10.0 (highest category). CI indicates confidence interval; and HR, hazard ratio.Show Less
  • You have accessRestricted access
    Association of Glycemic Control With Mortality in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
    Praneet K. Sharma, Shikhar Agarwal, Stephen G. Ellis, Sachin S. Goel, Leslie Cho, E. Murat Tuzcu, A. Michael Lincoff and Samir R. Kapadia
    Circulation: Cardiovascular Interventions. 2014;7:503-509, originally published August 5, 2014
    https://doi.org/10.1161/CIRCINTERVENTIONS.113.001107
    Download PDF
  • You have access
    Association of Glycemic Control With Mortality in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
    Praneet K. Sharma, Shikhar Agarwal, Stephen G. Ellis, Sachin S. Goel, Leslie Cho, E. Murat Tuzcu, A. Michael Lincoff, Samir R. Kapadia
    Circulation: Cardiovascular Interventions August 2014, 7 (4) 503-509; DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.113.001107
    View table
    Table 1.
    Baseline Characteristics of Patients Undergoing Percutaneous Coronary Intervention According to Baseline HbA1cShow More
    Baseline Characteristics of Patients Undergoing Percutaneous Coronary Intervention According to Baseline HbA1cShow Less
  • You have access
    Association of Glycemic Control With Mortality in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
    Praneet K. Sharma, Shikhar Agarwal, Stephen G. Ellis, Sachin S. Goel, Leslie Cho, E. Murat Tuzcu, A. Michael Lincoff, Samir R. Kapadia
    Circulation: Cardiovascular Interventions August 2014, 7 (4) 503-509; DOI: https://doi.org/10.1161/CIRCINTERVENTIONS.113.001107
    Figure 1.
    Figure 1.
    Adjusted all-cause mortality. Top, Age- and sex-adjusted all-cause mortality stratified acc...
    Show More
    Adjusted all-cause mortality. Top, Age- and sex-adjusted all-cause mortality stratified according to the hemoglobin A1c (HbA1c) level. Bottom, Respective estimates after multivariable adjustment using stepwise regression in a Cox proportional hazard model. All baseline demographic and clinical characteristics were entered into the model with a retention P value of 0.20. Besides the HbA1c category, the variables included in the final model were age, race, acute coronary syndrome, heart rate on presentation, systolic blood pressure on presentation, history of cerebrovascular accident, chronic obstructive pulmonary disease, renal failure, peripheral vascular occlusive disease, hypertension, family history of coronary artery disease, left main trunk disease, calcification, use of drug-eluting stent, and final thrombolysis in myocardial infarction flow <3. CI indicates confidence interval; and HR, hazard ratio.
    Show Less

Pages

  • 1
  • 2
  • Next Page
Back to top

Selected Facets

Selected Facets

  • Coronary Interventions (Article Type)

Subject

Subject

  • Catheter-based coronary interventions: stents 15
  • Type 2 diabetes 15

Content Type

Resource Type

  • Articles 1
  • Tables & Figures 14
Advertisement
Advertisement

Circulation

  • About Circulation
  • Instructions for Authors
  • Circulation CME
  • Statements and Guidelines
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451
email: circ@circulationjournal.org
 

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2017 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured